FDA Clears VisionBlue For Use In Ophthalmic Surgery
This article was originally published in The Pink Sheet Daily
Executive Summary
Dutch Ophthalmic’s VisionBlue is the first product approved for staining the anterior lens capsule during cataract surgery, FDA says. Safety and effectiveness of trypan blue ophthalmic solution were established in pediatric patients; no differences have been observed between elderly and younger patients.
You may also be interested in...
Dutch Ophthalmic’s VisionBlue Detailing Will Cite Sterility Problems With Compounded Versions
Custom Rx Compounding Pharmacy issues a nationwide recall of all unexpired syringes of trypan blue 0.06% ophthalmic solution following two reports of vision loss.
Dutch Ophthalmic’s VisionBlue Detailing Will Cite Sterility Problems With Compounded Versions
Custom Rx Compounding Pharmacy issues a nationwide recall of all unexpired syringes of trypan blue 0.06% ophthalmic solution following two reports of vision loss.
VisionBlue Ad, Website Omit Risk Information, FDA Warning Letter Says
Dutch Ophthalmic has posted a disclaimer on its website and plans to run corrective ads in response to the citation for failing to include risk information in marketing materials for the staining agent. WLF's "DDMAC Watch" is challenging FDA's warning letter on VisionBlue.